Angel News

Back to Homepage

2nd February 2024 - 0 comments

ALKemist Bio announces a €6.9M investment from IAG

Newly launched TCR company ALKemist Bio has closed a €6.9 million funding round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage